Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer
OPEN
1 other identifier
interventional
109
1 country
6
Brief Summary
Ovarian cancer patients are often at risk of malnutrition because of weight loss, lack of appetite and reduced food intake. Being malnourished can contribute to the incidence and severity of cancer treatment side effects and increase the risk of infection. Currently patients with advanced ovarian cancer do not receive early nutrition using a feeding tube. The purpose of this study is to compare enteral nutrition along with standard post-surgery care against current standard post-operative care alone. This study will see if early nutrition using a feeding tube has an impact on length of hospital admission, recovery from surgery, complications from surgery, nutritional status and ultimately a reduction in treatment costs in people with Advanced Epithelial Ovarian Cancer (EOC). Primary Peritoneal Cancer (PPC) or Fallopian Tube Cancer. Nutritional support has been shown to ;
- Prevent and treat under-nutrition,
- Enhance anti-tumour treatment effects,
- Reduce adverse effects of anti-tumour therapies,
- Improve quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Jan 2009
Longer than P75 for phase_3
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedFirst Submitted
Initial submission to the registry
February 23, 2009
CompletedFirst Posted
Study publicly available on registry
February 25, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2013
CompletedJune 12, 2014
June 1, 2014
4.6 years
February 23, 2009
June 10, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cost outcomes as represented by length of stay and cost effectiveness of enteral feeding / Quality of life
Compare treatment costs and cost effectiveness between early enteral feeding with standard post-operative care versus current standard ost-operative care for advanced epithelial ovarian cancer. Compare quality of life after surgery between women who receive early enteral feeding along with standard post-operative care versus those who receive current standard post-operative care for advanced epithelial ovarian cancer
End of study
Secondary Outcomes (5)
length of stay
Until discharge from hospital
Need for inotropic medications and intravenous treatment requirements
Until discharge from hospital
Nutritional status 6 weeks after surgery
6 weeks after surgery
Treatment related adverse events
End of study
Delay and dose reductions of chemotherapy / quality of life during chemotherapy
End of study
Study Arms (2)
Early post-operative enteral feeding
EXPERIMENTALStandard post-operative care and diet together with early post-operative enteral feeding
Standard post-operative care and diet
NO INTERVENTIONStandard post-operative care and diet only
Interventions
During primary surgical treatment an enteral feeding tube will be inserted through the patient's nose into their small bowel. Enteral feeding will commence 4 hours following return to ward from surgery. Feeding will start at a rate of 40 ml/hr for the first 24 hours, and then increased to goal weight. Goal will be calculated by 125 kiloJoules/kilogram adjusted body weight.
Eligibility Criteria
You may qualify if:
- Patients requiring planned primary surgery for suspected or histologically proven advanced ovarian, primary peritoneal cancer or fallopian tube cancer.
- Signs of moderate or severe malnutrition - Patient Generated Subjective Global Assessment (PG-SGA) Category B or C and/or a total numerical score of 4 or more in the PG-SGA
- Medically fit for primary surgery
- Signed written informed consent
- Females aged 18 years or older
You may not qualify if:
- Other histological type than ovarian cancer, peritoneal cancer or fallopian tube cancer
- Recurrent ovarian cancer, peritoneal or fallopian tube cancer
- Pre-existing contraindications to enteral nutrition such as ileus, gastrointestinal ischemia, bilious or persistent vomiting, or mechanical obstruction
- Positive urine pregnancy test
- Unfit for surgery; serious concomitant systemic disorders incompatible with the study (at the discretion of the investigator)
- Participation in other clinical trials that may have an impact on the outcomes of this trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
The Wesley Hospital
Auchenflower, Queensland, 4066, Australia
Brisbane Private Hospital
Brisbane, Queensland, 4000, Australia
Greenslopes Private Hospital
Greenslopes, Queensland, 4120, Australia
Royal Brisbane and Women's Hospital
Herston, Queensland, 4029, Australia
Mater Health Services
South Brisbane, Queensland, 4101, Australia
Gold Coast Hospital
Southport, Queensland, 4215, Australia
Related Publications (1)
Baker J, Janda M, Graves N, Bauer J, Banks M, Garrett A, Chetty N, Crandon AJ, Land R, Nascimento M, Nicklin JL, Perrin LC, Obermair A. Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial. Gynecol Oncol. 2015 Jun;137(3):516-22. doi: 10.1016/j.ygyno.2015.03.048. Epub 2015 Mar 28.
PMID: 25827292DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Andreas Obermair, MD FRANZCOG CGO
Queensland Centre for Gynaecological Cancer
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 23, 2009
First Posted
February 25, 2009
Study Start
January 1, 2009
Primary Completion
August 1, 2013
Study Completion
August 1, 2013
Last Updated
June 12, 2014
Record last verified: 2014-06